Picture of Consun Pharmaceutical logo

1681 Consun Pharmaceutical Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Annual income statement for Consun Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,8441,7281,7532,0452,340
Cost of Revenue
Gross Profit1,3841,2611,3221,5271,763
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,2001,5661,1481,3361,582
Operating Profit644163605709757
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes617134584696746
Provision for Income Taxes
Net Income After Taxes49763.1482587684
Minority Interest
Net Income Before Extraordinary Items
Net Income46579.8499590683
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income46579.8499590683
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.5330.2740.6110.7350.864
Dividends per Share